Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

3



Aripiprazole for maladaptive behavior in mental retardation: case reports

S. Ebru Çengel Kültür, Ahmet Tiryaki, Esra Taşgın.

Abstract
Aripiprazole is a new psychotropic agent that possesses a unique pharmacologic profile. The drug demonstrates partial dopamine agonist activity and has been labeled a third-generation antipsychotic and dopamine system stabilizer. We report on the use of aripiprazole in the treatment of maladaptive behaviors in three individuals (cases) with mental retardation. Three adolescents (two was (were) diagnosed as mental retardation and pervasive developmental disorder, one was diagnosed as mental retardation) received an open-label trial of aripiprazole with 5 to 10 mg/day. Drug response was evaluated by using the Aberrant Behavior Checklist, Conners Parent Rating Scale and Clinical Global Impressions- Improvement Scale first month after treatment. Side effects were followed by UKU Side Effect Rating Scale. Aripiprazole was well tolerated and somehow effective in all of the cases and appears to be a safe and efficacious alternative in the management of patients with both intellectual disabilities and pervasive developmental disorders. Only one of the patients was taken as treatment responder according to definition, the other two also had a slight improvement in clinical sense. Though short duration of treatment and relatively lower drug doses these results with aripiprazole indicate a probable treatment option in this difficult-to-treat population. Clinical studies are needed to clarify the effectiveness and safety of this medication.

Key words: Aripiprazole, mental retardation, child mental disorders, treatment



Share this Article


Advertisement
Journal of Complementary Medicine Research

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons